Antidepressants surprisingly don’t work for more than 40 percent of people who have Major Depressive Disorder, also known as clinical depression. People who live in the greater San Francisco area now have an option to have their clinical depression treated in an alternative way that is safe and easily accessible.
TMS Health Solutions is a healthcare firm that treats treatment-resistant forms of Major Depressive Disorder. Their patients have access to Transcranial Magnetic Stimulation which has been cleared for use by the FDA and is non-invasive. Over the course of several visits, they sit comfortably in a chair while a medical device sends magnetic waves into their head, triggering a specific part of the brain that is associated with clinical depression.
Richard Bermudes, MD, is the founder and chief medical officer of this firm. He has also been the president of the Clinical TMS Society. He has been a psychiatrist for more than 20 years and established TMS Health Solutions in 2007. He also has experience as a researcher and professor and has studied TMS therapy for years. Among the books he has written is, “Transcranial Magnetic Stimulation: Clinical Adaptions for Psychiatric Practice”.
Currently, TMS Solutions has six clinics in the Bay Area. They are planning to have 25 clinics across Northern California within the next few years. Their leaders are nationally recognized experts in clinical depression, TMS, and offer mental health care that is built upon compassion and offering a comprehensive approach.
Due to this firm’s practice model they can offer their patients flexibility when it comes to scheduling TMS sessions. Another benefit of the approach at TMS Health Solutions is that the people working there can take care of their own mental health as this firm offers a reasonable work-life balance so that their employees can enjoy their activities, friends, and family outside of the workplace. They also encourage an entrepreneurial spirit among the executive and staff members and support actively researching new therapies for their patients.